Grufity logoGrufity logo
StocksFundsSearch Filings

Envista Holdings Corp Stock Research

NVST

32.96USD+0.72(+2.23%)Delayed

Market Summary

USD32.96+0.72
Delayed
2.23%

NVST Alerts

NVST Stock Price

NVST RSI Chart

NVST Valuation

Market Cap

5.4B

Price/Earnings (Trailing)

25.45

Price/Sales (Trailing)

2.1

EV/EBITDA

14.34

Price/Free Cashflow

49.55

NVST Price/Sales (Trailing)

NVST Profitability

EBT Margin

11.05%

Return on Equity

5.78%

Return on Assets

3.69%

Free Cashflow Yield

2.02%

NVST Fundamentals

NVST Revenue

Revenue (TTM)

2.6B

Revenue Y/Y

-0.67%

Revenue Q/Q

-5.08%

NVST Earnings

Earnings (TTM)

212.0M

Earnings Y/Y

-41.52%

Earnings Q/Q

-40.41%

Price Action

52 Week Range

31.2043.94
(Low)(High)

Last 7 days

-0.9%

Last 30 days

-12.4%

Last 90 days

-17.0%

Trailing 12 Months

-24.9%

NVST Financial Health

Current Ratio

1.15

Debt/Equity

0.35

Debt/Cashflow

0.15

NVST Investor Care

Shares Dilution (1Y)

0.68%

Diluted EPS (TTM)

1.2

Peers (Alternatives to Envista Holdings)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
111.4B
30.8B
-7.64% -14.31%
27.36
3.62
-3.19% -17.32%
110.8B
19.0B
-3.08% 19.15%
46.98
6.01
8.73% 30.37%
109.4B
6.4B
2.33% 37.40%
83.37
17.01
8.89% -20.19%
71.3B
18.8B
-4.48% 0.69%
44.09
3.79
-1.96% -15.83%
51.7B
5.5B
-3.13% -15.68%
34.74
9.4
2.68% -3.23%
MID-CAP
7.2T
557.2M
2.76% 73.14%
82.2K
16.8K
86.42% 730.06%
12.2B
884.6M
6.58% 119.77%
1.9K
13.82
13.08% 200.12%
5.9B
1.1B
-1.81% -16.23%
34.14
5.75
11.20% 53.04%
3.2B
430.0M
-20.57% -26.17%
-30.76
7.49
26.13% 15.73%
1.6B
794.7M
-38.00% -63.12%
-7.85
2.01
7.73% -3556.34%
SMALL-CAP
1.2B
150.7M
-27.51% -13.57%
-21.41
7.78
40.31% 1.80%
1.2B
814.3M
1.60% -13.09%
25.98
1.42
6.96% 121.89%
1.0B
163.2M
31.07% 63.84%
-6.86
6.15
17.84% -885.82%
839.3M
239.8M
0.70% 0.15%
-22.16
3.5
-4.74% -31.15%

Financials for Envista Holdings

Income Statement (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q12022Q42022Q32022Q22022Q1
Revenue-0.2%2,5652,5692,5602,5362,528
Gross Profit-0.8%1,4631,4751,4521,4431,442
  S&GA Expenses0.7%1,0631,0561,0741,0611,041
  R&D Expenses0.1%10010010098.0099.00
EBITDA12.4%354315324436-
EBITDA Margin12.0%0.14*0.12*0.13*0.17*-
Earnings Before Taxes-10.6%254284245252263
EBT Margin15.3%0.11*0.10*0.10*0.11*-
Interest Expenses28.1%49.0038.0034.0035.0042.00
Net Income-12.8%212243212257300
Net Income Margin14.2%0.09*0.08*0.10*0.11*-
Free Cahsflow-24.1%107141192282-
Balance Sheet
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q12022Q42022Q32022Q22022Q1
Assets-0.2%6,5756,5876,4126,4616,572
  Current Assets-0.7%1,4141,4251,3661,3881,909
    Cash Equivalents-3.6%5856075695231,078
  Inventory2.1%307301291286280
  Net PPE1.4%298294277264264
  Goodwill0.3%3,5063,4973,40077.003,091
  Current Liabilities-7.0%1,1501,2371,2581,2561,256
.    Short Term Borrowings0.2%511510579509508
  Long Term Debt-0.9%1,3731,385---
    LT Debt, Non Current0.4%874871852864877
Shareholder's Equity6.3%4,2073,9584,0164,031-
  Retained Earnings6.0%775731658610563
  Additional Paid-In Capital0.4%3,7133,6993,6903,6783,668
Shares Outstanding0.3%164163163163163
Minority InterestNaN%-----
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2023Q12022Q42022Q32022Q22022Q1
Cashflow From Operations-0.2%182183208250349
  Share Based Compensation24.6%38.0031.0030.0030.0029.00
Cashflow From Investing-4.1%-684-657-367-301273
Cashflow From Financing-54.4%6.0013.0083.005.009.00

Risks for NVST

What is the probability of a big loss on NVST?

57.4%


Probability that Envista Holdings stock will be more than 20% underwater in next one year

41.5%


Probability that Envista Holdings stock will be more than 30% underwater in next one year.

26.1%


Probability that Envista Holdings stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does NVST drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Envista Holdings was unfortunately bought at previous high price.

Drawdowns

Returns for NVST

Cumulative Returns on NVST

15.2%


3-Year Cumulative Returns

Which funds bought or sold NVST recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-06-01
MACQUARIE GROUP LTD
added
14.44
47,639,000
169,954,000
0.20%
2023-05-26
ProShare Advisors LLC
reduced
-22.41
-24,442
396,904
-%
2023-05-23
Brookfield Corp /ON/
added
158
8,120,500
11,914,800
0.05%
2023-05-23
Front Row Advisors LLC
sold off
-100
-4,000
-
-%
2023-05-23
Toroso Investments, LLC
new
-
584,000
584,000
0.01%
2023-05-22
Raleigh Capital Management Inc.
sold off
-100
-1,447
-
-%
2023-05-22
American Trust
new
-
225,903
225,903
0.02%
2023-05-22
AMERIPRISE FINANCIAL INC
added
0.63
1,575,130
8,678,130
-%
2023-05-18
JPMORGAN CHASE & CO
added
6.62
25,970,000
114,135,000
0.01%
2023-05-18
NEW YORK STATE COMMON RETIREMENT FUND
reduced
-4.09
2,174,000
15,388,000
0.02%

1–10 of 36

Latest Funds Activity

Are funds buying NVST calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own NVST
No. of Funds

Envista Holdings News

Defense World
Pershing Square (OTCMKTS:PSHZF) Stock Price Passes Above 50 ....
Defense World,
3 days ago
Orange County Business Journal
Larger Health Firms Report Mixed Q1 Results.
Orange County Business Journal,
18 days ago
InvestorsObserver

Schedule 13G FIlings of Envista Holdings

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Mar 09, 2023
lazard asset management llc
7.37%
12,032,931
SC 13G
Mar 09, 2023
lazard asset management llc
7.37%
12,032,931
SC 13G
Mar 08, 2023
lazard asset management llc
7.37%
12,032,931
SC 13G
Feb 09, 2023
morgan stanley
8.3%
13,484,631
SC 13G/A
Feb 09, 2023
fmr llc
-
0
SC 13G/A
Feb 09, 2023
vanguard group inc
9.81%
15,996,062
SC 13G/A
Feb 08, 2023
massachusetts financial services co /ma/
6.1%
9,878,126
SC 13G
Jan 26, 2023
blackrock inc.
11.4%
18,558,830
SC 13G/A
Jan 20, 2023
blackrock inc.
11.4%
18,558,830
SC 13G/A
Feb 14, 2022
price t rowe associates inc /md/
0.1%
170,528
SC 13G/A

NVST Fair Value

Show Fair-Value

Recent SEC filings of Envista Holdings

View All Filings
Date Filed Form Type Document
May 31, 2023
4
Insider Trading
May 31, 2023
SD
SD
May 26, 2023
8-K
Current Report
May 25, 2023
4
Insider Trading
May 25, 2023
4
Insider Trading
May 25, 2023
4
Insider Trading
May 25, 2023
4
Insider Trading
May 25, 2023
4
Insider Trading
May 25, 2023
4
Insider Trading
May 25, 2023
4
Insider Trading

Latest Insider Trading transactions for NVST

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-05-25
Conley Eric
sold (taxes)
-21,153
32.95
-642
svp, orthodontics
2023-05-23
Hulit Barbara B.
acquired
-
-
5,425
-
2023-05-23
Carruthers Wendy
acquired
-
-
5,425
-
2023-05-23
Huennekens R Scott
acquired
-
-
7,625
-
2023-05-23
Jain Vivek
acquired
-
-
5,425
-
2023-05-23
GALLAHUE KIERAN
acquired
-
-
5,425
-
2023-05-23
Raskas Daniel
acquired
-
-
5,425
-
2023-05-23
TSINGOS CHRISTINE A
acquired
-
-
5,425
-
2023-02-28
Yu Howard H
sold
-379,606
37.9
-10,016
chief financial officer
2023-02-25
Conley Eric
sold (taxes)
-24,097
38.25
-630
svp, orthodontics

1–10 of 50

Amir A. Aghdaei
11200
Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, and Orascoptic brands; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Insignia, AOA, and Spark brands. This segment also offers software packages, which include DTX Studio Implant for treatment planning of dental implants; TX Studio Lab for prosthetics treatment planning; and DTX Studio Clinic to store and access a various clinical patient images. The company's Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, sensors, software, and other visualization/magnification systems; endodontic systems and related consumables; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

NVST Income Statement

2023-03-31
Condensed Consolidated Statements of Operations (unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2023
Apr. 01, 2022
Income Statement [Abstract]  
Sales$ 627.2$ 631.4
Cost of sales264.5257.3
Gross profit362.7374.1
Operating expenses:  
Selling, general and administrative266.1258.2
Research and development24.524.4
Operating profit72.191.5
Nonoperating income (expense):  
Other income0.30.3
Interest expense, net(16.7)(5.9)
Income before income taxes55.785.9
Income tax expense11.915.5
Income from continuing operations, net of tax43.870.4
Income from discontinued operations, net of tax (Note 3)0.04.5
Net income$ 43.8$ 74.9
Earnings per share:  
Earnings from continuing operations - basic (in USD per share)$ 0.27$ 0.43
Earnings from continuing operations - diluted (in USD per share)0.250.39
Earnings (loss) from discontinued operations - basic (in USD per share)00.03
Earnings (loss) from discontinued operations - diluted (in USD per share)00.03
Earnings - basic (in USD per share)0.270.46
Earnings - diluted (in USD per share)$ 0.25$ 0.42
Average common stock and common equivalent shares outstanding:  
Basic (in shares)163.6162.2
Diluted (in shares)177.4179.8

NVST Balance Sheet

2023-03-31
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 585.2$ 606.9
Trade accounts receivable, less allowance for credit losses of $16.0 and $16.2, respectively401.8393.5
Inventories, net307.2300.8
Prepaid expenses and other current assets120.1123.4
Total current assets1,414.31,424.6
Property, plant and equipment, net297.6293.6
Operating lease right-of-use assets132.9131.8
Other long-term assets158.3153.7
Goodwill3,506.43,496.6
Other intangible assets, net1,065.51,086.7
Total assets6,575.06,587.0
Current liabilities:  
Short-term debt510.8510.0
Trade accounts payable186.8228.3
Accrued expenses and other liabilities423.6471.4
Operating lease liabilities28.427.0
Total current liabilities1,149.61,236.7
Operating lease liabilities121.3121.4
Other long-term liabilities151.3151.3
Long-term debt873.8870.7
Commitments and contingencies
Stockholders’ equity:  
Preferred stock, $0.01 par value, 15.0 million shares authorized; no shares issued or outstanding at March 31, 2023 and December 31, 20220.00.0
Common stock - $0.01 par value, 500.0 million shares authorized; 164.4 million shares issued and 163.7 million shares outstanding at March 31, 2023; 163.7 million shares issued and 163.2 million shares outstanding at December 31, 20221.61.6
Additional paid-in capital3,712.83,699.0
Retained earnings775.2731.4
Accumulated other comprehensive loss(210.6)(225.1)
Total stockholders’ equity4,279.04,206.9
Total liabilities and stockholders’ equity$ 6,575.0$ 6,587.0